Table 1 |
||||
|
Demographics of the inception cohort (n = 208) |
||||
|
GG |
GA+AA |
|||
|
Number |
(n = 138) |
(n = 64 + 6) |
P-value |
|
|
|
||||
|
Age, years, mean (SD) |
52 (13) |
50 (13) |
0.21 |
|
|
Female gender, n (%) |
89 (64%) |
50 (71%) |
0.32 |
|
|
RF positivity, n (%) |
105 (76%) |
55 (79%) |
0.69 |
|
|
DAS28, mean (SD) |
||||
|
Baseline |
208 |
5.2 (1.4) |
5.3 (1.3) |
0.38 |
|
3-year average |
208 |
4.0 (1.1) |
3.9 (1.0) |
0.85 |
|
6-year average |
159 |
4.0 (1.0) |
3.7 (1.0) |
0.10 |
|
9-year average |
115 |
4.0 (1.0) |
3.7 (1.0) |
0.12 |
|
Patients with erosions at baseline, n (%) |
208 |
76 (55%) |
44 (63%) |
0.28 |
|
Ratingen score, median (range) |
||||
|
Baseline |
208 |
0 (0-2) |
0 (0-2) |
0.17 |
|
3 years |
208 |
7 (0-15) |
4 (0-10) |
0.08 |
|
6 years |
160 |
12 (2-26) |
10 (1-21) |
0.18 |
|
9 years |
116 |
22 (10-38) |
14 (3-24) |
0.07 |
|
|
||||
|
Percentages are expressed in relation to the total number of patients for each genotype group. RF, rheumatoid factor; DAS28, 28-joint disease activity score. |
||||
|
Toonen et al. Arthritis Research & Therapy 2012 14:R264 doi:10.1186/ar4110 |
||||